Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxelox: Oxaliplatin/Docetaxel vs Cisplatin/Docetaxel in Advanced NSCLC
NCT01222312Phase 2Completed
- Sponsor
- Krankenhaus Nordwest
- Start
- Aug 2008
- Primary completion
- Oct 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in non-small cell lung cancer (NSCLC), sponsored by Krankenhaus Nordwest. Started Aug 2008; status: completed.
02
Drugs
oxaliplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01222312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01222312.